Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Regeneron Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Saturday, September 10, 2011 - 9:55am
tags:
Regeneron, Eylea, age-related macular degeneration
Dendreon: Righting The Ship
Seeking Alpha
Saturday, September 10, 2011 - 9:54am
tags:
Dendreon
Neuvenge: Dendreon's Treatment For Bladder Cancer
Seeking Alpha
Saturday, September 10, 2011 - 9:53am
tags:
Neuvenge, Dendreon, bladder cancer
GSK stops Tykerb-only arm in cancer trial
Fierce Pharma
Friday, September 9, 2011 - 12:02pm
tags:
GSK, Tykerb, Roche, Herceptin, breast cancer
[video] The Next Big Thing in Biotech: Immunogen
TheStreet.com
Friday, September 9, 2011 - 11:59am
tags:
Immunogen
Are Shorts Watching This Number at Novo Nordisk?
Motley Fool
Friday, September 9, 2011 - 11:57am
tags:
Novo Nordisk
Sanofi Projects Growth Despite Challenges
Seeking Alpha
Friday, September 9, 2011 - 11:47am
tags:
Sanofi, Plavix, Avapro
Anti-Clotting Stumble For J&J/Bayer Likely to Help Pfizer/Bristol-Meyers
Seeking Alpha
Friday, September 9, 2011 - 11:36am
tags:
JNJ, Bayer, Pfizer, Bristol-Myers Squibb, Xarelto
Patent Reform, A Drugmaker & A Special Favor
Pharmalot
Friday, September 9, 2011 - 11:30am
tags:
patents, Medicines Company
Citi analyst expects FDA approval of J&J anticlotting drug after committee recommendatio
Yahoo/AP
Friday, September 9, 2011 - 11:23am
tags:
FDA, JNJ, Xarelto, bloodthinners, Bayer
Novartis AG: Dividend Stock Analysis
Seeking Alpha
Friday, September 9, 2011 - 11:21am
tags:
dividends, Novartis
Bayer targeted by 53 plaintiffs in St. Clair County 'Yaz' suit
Madison Record, WI
Friday, September 9, 2011 - 10:21am
tags:
Bayer, lawsuits, Yaz, birth control pill
Pfizer starts animal health joint venture in China
Yahoo/AP
Friday, September 9, 2011 - 10:19am
tags:
China, Pfizer, animal health, Jilin Guoyuan Animal Health Company
Duke, Allergan sue Hi-Tech Pharmacal over eyelash lengthener Latisse
Bizjournals.com
Friday, September 9, 2011 - 10:18am
tags:
Allergan, Hi-Tech Pharmacal, Latisse
Bayer Jumps 5.6% in L&S Pre-Market Trading on FDA Panel Backing
Bloomberg
Friday, September 9, 2011 - 10:15am
tags:
Bayer, FDA, Xarelto, JNJ
Dendreon Cuts Staff By 25%; High-Level Exec Departs
WSJ Online
Friday, September 9, 2011 - 9:56am
tags:
layoffs, Dendreon
J&J: FDA Panel Recommends New Approved Use for Xarelto
Barron's
Friday, September 9, 2011 - 9:54am
tags:
Xarelto, JNJ, FDA, bloodthinners, advisory panels, Bayer
Top drugmakers spent $220M on doctor-speakers
Fierce Pharma
Thursday, September 8, 2011 - 1:01pm
tags:
physician payments
Pfizer’s Arthritis Pill Matches Abbott’s Shot in Studies
Bloomberg
Thursday, September 8, 2011 - 12:52pm
tags:
Pfizer, Abbott Laboratories, tofacitinib, rheumatoid arthritis
Live Blog-- FDA Advisory Panel on Rivaroxaban (Xarelto)
Forbes
Thursday, September 8, 2011 - 12:50pm
tags:
Xarelto, JNJ, FDA, Bayer, advisory panels

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.